Exploring how bacteria use protein processes to fight viruses
Understanding the role of ubiquitination-like processes in bacterial antiviral immunity
This study looks at how bacteria use special proteins to fight off viruses, similar to how our bodies do, and it hopes to find new ways to help develop antiviral treatments that could benefit patients.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado NIH-funded |
| Lab location | 1 site (Boulder, UNITED STATES) |
| Project ID | NIH-11165584 on NIH RePORTER |
What this research studies
This research investigates how bacteria utilize unique protein processes, similar to those in humans, to defend against viral infections. By examining the role of ubiquitination-like mechanisms in bacterial antiviral immunity, the study aims to uncover the molecular pathways that enable bacteria to recognize and combat viral threats. The approach involves a multidisciplinary strategy that combines biochemistry, bioinformatics, and cellular biology to analyze these immune responses at a detailed level. Patients may benefit from insights gained into these processes, which could inform the development of new antiviral therapies.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with viral infections or those interested in the mechanisms of antiviral immunity.
Not a fit: Patients with non-viral infections or conditions unrelated to antiviral immunity may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative strategies for enhancing antiviral treatments in humans.
How similar studies have performed: While the specific approach of investigating bacterial antiviral immunity through ubiquitination-like processes is relatively novel, similar research has shown promise in understanding immune responses in other contexts.
Where this research is happening
Boulder, UNITED STATES
- University of Colorado — Boulder, United States (Active)
Researchers
- Principal investigator: Sullivan, Ashley Elizabeth — University of Colorado
- Study coordinator: Sullivan, Ashley Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.